1 – 2 of 2 jobs
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
We are a Pharma and Life Science IT service provider that has been successfully carrying out state-of-the-art projects for international customers for more than 30 years, now. Our consultants work from home on our customer’s premises
Recommended jobs for you
